...
首页> 外文期刊>Sao Paulo Medical Journal >Autoimmune and non-autoimmune thyroid diseases have different patterns of cellular HLA class II expression
【24h】

Autoimmune and non-autoimmune thyroid diseases have different patterns of cellular HLA class II expression

机译:自身免疫性和非自身免疫性甲状腺疾病具有不同的细胞HLA II类表达模式

获取原文
           

摘要

CONTEXT: Surface HLA-DR antigen is usually only expressed by antigen-presenting cells (APC). In autoimmune thyroid disease, follicle cells function as APC, thus expressing HLA-DR. However, non-autoimmune thyroid diseases may also express surface class II antigens. OBJECTIVE: To evaluate the presence and pattern of HLA class II expression in autoimmune and non-autoimmune thyroid disorders. DESIGN: Retrospective: histopathological and immunohistochemical analysis. LOCATION: Referral center, university hospital. SAMPLE: Ten histologically normal thyroids, 11 Graves’ disease, 7 Hashimoto’s thyroiditis, 10 atoxic multinodular goiter and 3 toxic adenomas were analyzed by immunohistochemistry, using a monoclonal antibody anti-HLA-DR. MAIN MEASUREMENTS: The presence of these antigens in thyroid follicular cells and their relation to inflammatory infiltrate was evaluated. The pattern of HLA-DR expression in thyroid follicular cells was analyzed: membrane, cytoplasmic or both. RESULTS: Although HLA-DR antigens were sparsely present in one of the 8 normal thyroids, in 6 of the 9 atoxic multinodular goiter and in 2 of the 3 toxic adenomas a net positivity could be seen in large areas. In all 5 Hashimoto’s thyroiditis and in 7 of the 10 Graves’ disease cases. This expression occurred in follicle cells either in contact with inflammatory cells or not. In non-autoimmune thyroid disease, HLA-DR positivity was essentially cytoplasmic, whereas in Graves’ disease and Hashimoto thyroiditis it was mainly in cell membranes. CONCLUSIONS: It is suggested that the HLA class II expression on the surface of follicle cells could be related to auto-antigen presentation to the immune system by these cells, leading to inflammation.
机译:背景:表面HLA-DR抗原通常仅由抗原呈递细胞(APC)表达。在自身免疫性甲状腺疾病中,卵泡细胞起APC的作用,从而表达HLA-DR。但是,非自身免疫性甲状腺疾病也可能表达II类表面抗原。目的:评估自身免疫性和非自身免疫性甲状腺疾病中HLA II类表达的存在和模式。设计:回顾性:组织病理学和免疫组化分析。地点:大学医院转诊中心。样本:使用单克隆抗体抗HLA-DR,通过免疫组织化学分析了10例组织学正常的甲状腺,11例Graves病,7例桥本甲状腺炎,10例无毒性多结节性甲状腺肿和3例毒性腺瘤。主要测量:评估了甲状腺滤泡细胞中这些抗原的存在及其与炎性浸润的关系。分析了甲状腺滤泡细胞中HLA-DR表达的模式:膜,细胞质或两者。结果:尽管HLA-DR抗原稀疏地存在于8个正常甲状腺之一中,但在9个无毒性多结节性甲状腺肿中有6个和在3个毒性腺瘤中有2个在大面积上可以看到净阳性。在所有5例桥本氏甲状腺炎和10例Graves病病例中,有7例。这种表达发生在与炎性细胞接触或没有接触的卵泡细胞中。在非自身免疫性甲状腺疾病中,HLA-DR阳性本质上是细胞质,而在格雷夫斯病和桥本甲状腺炎中则主要在细胞膜中。结论:卵泡细胞表面HLA II类表达可能与这些细胞向免疫系统呈递自身抗原有关,从而导致炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号